Fate Therapeutics, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct's, 'Fate Therapeutics, Inc. - Product Pipeline Review - 2016', provides an overview of the Fate Therapeutics, Inc.'s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Fate Therapeutics, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of Fate Therapeutics, Inc. - The report provides overview of Fate Therapeutics, Inc. including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses Fate Therapeutics, Inc.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features Fate Therapeutics, Inc.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons To Buy - Evaluate Fate Therapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Fate Therapeutics, Inc. - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Fate Therapeutics, Inc.'s pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 Fate Therapeutics, Inc. Snapshot 5 Fate Therapeutics, Inc. Overview 5 Key Information 5 Key Facts 5 Fate Therapeutics, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Fate Therapeutics, Inc. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Partnered Products 10 Partnered Products/Combination Treatment Modalities 11 Fate Therapeutics, Inc. - Pipeline Products Glance 12 Fate Therapeutics, Inc. - Early Stage Pipeline Products 12 IND/CTA Filed Products/Combination Treatment Modalities 12 Preclinical Products/Combination Treatment Modalities 13 Discovery Products/Combination Treatment Modalities 14 Fate Therapeutics, Inc. - Drug Profiles 15 ProTmune 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 Cellular Immunotherapy for Solid Tumors and Hematological Tumors 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 Stem Cell Therapy 2 for Undisclosed Indication 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 Stem Cell Therapy for Hearing Disorders 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 Stem Cell Therapy for Hematological and Solid Tumors 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Stem Cell Therapy for Inflammation and Autoimmune Diseases 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 Stem Cell Therapy for Lysosomal Storage Disorder 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Stem Cell Therapy for Solid Tumors and Hematologic Malignancies 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 Stem Cell Therapy for Musculoskeletal Disorders 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 Stem Cell Therapy 1 for Undisclosed Indication 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 Fate Therapeutics, Inc. - Pipeline Analysis 25 Fate Therapeutics, Inc. - Pipeline Products by Molecule Type 25 Fate Therapeutics, Inc. - Recent Pipeline Updates 26 Fate Therapeutics, Inc. - Dormant Projects 27 Fate Therapeutics, Inc. - Discontinued Pipeline Products 28 Discontinued Pipeline Product Profiles 28 FT-1050 28 Fate Therapeutics, Inc. - Locations And Subsidiaries 29 Head Office 29 Other Locations & Subsidiaries 29 Appendix 30 Methodology 30 Coverage 30 Secondary Research 30 Primary Research 30 Expert Panel Validation 30 Contact Us 30 Disclaimer 31
List of Tables
Fate Therapeutics, Inc., Key Information 5 Fate Therapeutics, Inc., Key Facts 5 Fate Therapeutics, Inc. - Pipeline by Indication, 2016 7 Fate Therapeutics, Inc. - Pipeline by Stage of Development, 2016 8 Fate Therapeutics, Inc. - Monotherapy Products in Pipeline, 2016 9 Fate Therapeutics, Inc. - Partnered Products in Pipeline, 2016 10 Fate Therapeutics, Inc. - Partnered Products/ Combination Treatment Modalities, 2016 11 Fate Therapeutics, Inc. - IND/CTA Filed, 2016 12 Fate Therapeutics, Inc. - Preclinical, 2016 13 Fate Therapeutics, Inc. - Discovery, 2016 14 Fate Therapeutics, Inc. - Pipeline by Molecule Type, 2016 25 Fate Therapeutics, Inc. - Recent Pipeline Updates, 2016 26 Fate Therapeutics, Inc. - Dormant Developmental Projects,2016 27 Fate Therapeutics, Inc. - Discontinued Pipeline Products, 2016 28 Fate Therapeutics, Inc., Subsidiaries 29
List of Figures
Fate Therapeutics, Inc. - Pipeline by Top 10 Indication, 2016 7 Fate Therapeutics, Inc. - Pipeline by Stage of Development, 2016 8 Fate Therapeutics, Inc. - Monotherapy Products in Pipeline, 2016 9 Fate Therapeutics, Inc. - Pipeline by Molecule Type, 2016 25
Global automotive collision repair market is expected to be valued at USD 196.97 billion by 2020, as per a new research report by Radiant Insights, Inc. The industry is expected to witness significant growth owing to increasing number of on-road vehiRead More...
Global automotive coatings market size is likely to be valued at USD 27.7 billion by 2022; as per a new research report by Radiant Insights, Inc. Vehicle aesthetics, UV radiation and temperature variation protection and enhance durability are certainRead More...
Global animal feed additives market size was estimated at USD 16 billion in 2014. Growing meat consumption as a key protein source, especially in Asia Pacific and Latin America is expected to be a key driver for market demand over the forecast periodRead More...
Global 3D scanning market is expected to be valued at USD 4,900.7 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing need for speedy and precise results with high efficiency is anticipated to drive the industry. 3DRead More...
Global aerospace plastics market size is likely to be valued at USD 13.48 billion by 2020; as per a new research report by Radiant Insights, Inc. Growing application scope of lightweight materials in aerospace industry is likely to drive market growtRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.